Cargando…
Detection of NRAS mutation in cell-free DNA biological fluids from patients with kaposiform lymphangiomatosis
BACKGROUND: Kaposiform lymphangiomatosis (KLA) has recently been distinguished as a novel subtype of generalized lymphatic anomaly (GLA) with foci of spindle endothelial cells. All cases of KLA involve multiple organs and have an unfavorable prognosis. However, the molecular pathogenesis is unknown,...
Autores principales: | Ozeki, Michio, Aoki, Yoko, Nozawa, Akifumi, Yasue, Shiho, Endo, Saori, Hori, Yumiko, Matsuoka, Kentaro, Niihori, Tetsuya, Funayama, Ryo, Shirota, Matsuyuki, Nakayama, Keiko, Fukao, Toshiyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737666/ https://www.ncbi.nlm.nih.gov/pubmed/31511039 http://dx.doi.org/10.1186/s13023-019-1191-5 |
Ejemplares similares
-
A Somatic Activating NRAS Variant Associated with Kaposiform Lymphangiomatosis
por: Barclay, Sarah F., et al.
Publicado: (2018) -
Treatment of severe Kaposiform Lymphangiomatosis positive for NRAS mutation by MEK-inhibition
por: Chowers, Guy, et al.
Publicado: (2022) -
The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies
por: Ozeki, Michio, et al.
Publicado: (2019) -
Kaposiform lymphangiomatosis and kaposiform hemangioendothelioma: similarities and differences
por: Ji, Yi, et al.
Publicado: (2019) -
Sirolimus in the treatment of kaposiform lymphangiomatosis
por: Zhou, Jiangyuan, et al.
Publicado: (2021)